Showing 221 - 240 results of 1,859 for search '"Immunotherapy"', query time: 0.06s Refine Results
  1. 221
  2. 222

    Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer by Kuang Youlin, Zhang Li, Weng Xiaodong, Liu Xiuheng, Zhu Hengchen

    Published 2012-01-01
    “…These results suggest that combining activation of 4-1BB and blockade of CTLA-4 may offer a new strategy for prostate cancer immunotherapy.…”
    Get full text
    Article
  3. 223

    The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature by Ioanna Tsiouprou, Athanasios Zaharias, Dionisios Spyratos

    Published 2019-01-01
    “…Nevertheless, prognostic biomarkers to immunotherapy response remain to be discovered.…”
    Get full text
    Article
  4. 224

    Immunotherapy versus targeted therapy in management of recurrent squamous cell carcinoma of oral tongue by Nadimul Hoda, Aastha Moza, K.P. Amith, K.S. Sabitha

    Published 2024-06-01
    “…Background: Targeted therapies, and more recently immunotherapy, have dramatically changed the landscape of treatments in oral cavity cancers and improved clinical outcomes. …”
    Get full text
    Article
  5. 225
  6. 226
  7. 227
  8. 228

    Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy by Jie Ma, Hongtao Wang, Zhengwei Gui, Yuanrong Yang

    Published 2025-01-01
    “…SYNGR4 overexpression affects breast cancer proliferation, migration, and tumor immune infiltration, and promotes breast cancer tumor-associated macrophage polarization toward M2.DiscussionSYNGR4 overexpression can affect the prognosis of breast cancer patients by promoting M2 polarization of tumor-associated macrophages in breast cancer, and this molecule may be a novel target for breast cancer immunotherapy.…”
    Get full text
    Article
  9. 229
  10. 230

    A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy by Jin Bian, Yan Niu, Yanli Ma, Fuhua Chen, Ning Ma

    Published 2022-01-01
    “…Although radiotherapy and chemotherapy are effective treatments for NPC, they have immunosuppressive effects. Immunotherapy has got considerable attention of clinicians for cancer treatment in recent years due to proven success of PD-1/PD-L 1 inhibition in solid tumors trials. …”
    Get full text
    Article
  11. 231
  12. 232
  13. 233
  14. 234
  15. 235

    Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer by M. Kamrava, Kwong Y. Tsang, R. A. Madan, A. Kaushal, C. N. Coleman, J. Gulley

    Published 2009-01-01
    “…We describe a patient with node positive prostate cancer treated with radiation, androgen deprivation, and immunotherapy with long-term overall survival and PSA control. …”
    Get full text
    Article
  16. 236
  17. 237

    Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies by Li-Chun Lu, Gen-Sheng Feng, Chih-Hung Hsu

    Published 2023-04-01
    “…Objective: Immunotherapy with immune checkpoint inhibitors (ICIs) has become a standard of care for many malignancies. …”
    Get full text
    Article
  18. 238
  19. 239
  20. 240

    Gene Carriers and Transfection Systems Used in the Recombination of Dendritic Cells for Effective Cancer Immunotherapy by Yu-Zhe Chen, Xing-Lei Yao, Yasuhiko Tabata, Shinsaku Nakagawa, Jian-Qing Gao

    Published 2010-01-01
    “…Therefore, it is essential to improve the transfection efficiency of DC-based vaccination in immunotherapy. In several studies, DCs were genetically engineered by tumor-associated antigens or by immune molecules such as costimulatory molecules, cytokines, and chemokines. …”
    Get full text
    Article